A randomized, double-blind trial comparing the effect of fluticasone/salmeterol 250/50 to salmeterol on COPD exacerbations in patients with COPD

被引：0
|
作者：
Ferguson, Gary [1 ]
Anzueto, Antonio [1 ]
Fei, Richard [1 ]
Emmett, Amanda [1 ]
Crater, Glenn [1 ]
Knobil, Kate [1 ]
Kalberg, Chris [1 ]
机构：
[1] Pulm Res Inst SE Michigan, Livonia, MI USA
来源：
CHEST | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：530S / 531S
页数：2
相关论文
共 50 条
  • [1] Effect of fluticasone propionate/salmeterol (250/50 μg) or salmeterol (50 μg) on COPD exacerbations
    Ferguson, Gary T.
    Anzueto, Antonio
    Fei, Richard
    Emmett, Amanda
    Knobil, Katharine
    Kalberg, Christopher
    RESPIRATORY MEDICINE, 2008, 102 (08) : 1099 - 1108
  • [2] Effect of Fluticasone Propionate/Salmeterol (250/50) on COPD Exacerbations and Impact on Patient Outcomes
    Anzueto, Antonio
    Ferguson, Gary T.
    Feldman, Greg
    Chinsky, Kenneth
    Seibert, Allan
    Emmett, Amanda
    Knobil, Katharine
    O'Dell, Dianne
    Kalberg, Christopher
    Crater, Glenn
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2009, 6 (05) : 320 - 329
  • [3] Effect Of Fluticasone Propionate/Salmeterol (250/50) On Arterial Stiffness In Patients With COPD
    Dransfield, M. T.
    Cockcroft, J.
    Townsend, R.
    Coxson, H. O.
    Sharma, S.
    Rubin, D.
    Emmett, A.
    Cicale, M.
    Crater, G.
    Martinez, F. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [4] Effect of fluticasone propionate/salmeterol 250/50 on lung hyperinflation and exercise endurance in patients with COPD
    O'Donnell, DE
    Sciurba, F
    Celli, B
    Mahler, DA
    Webb, K
    Kalberg, C
    Crater, C
    Knobil, K
    CHEST, 2005, 128 (04) : 178S - 178S
  • [5] Efficacy And Safety Of Umeclidinium Added To Fluticasone Propionate/salmeterol In Patients With COPD: Results Of A Randomized, Double-Blind Study
    Kerwin, E.
    Shah, P.
    Singletary, K.
    Church, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [6] Efficacy and Safety of Umeclidinium Added to Fluticasone Propionate/Salmeterol in Patients with COPD: Results of Two Randomized, Double-Blind Studies
    Siler, Thomas M.
    Kerwin, Edward
    Singletary, Karen
    Brooks, Jean
    Church, Alison
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 13 (01) : 1 - 10
  • [7] Effect of Fluticasone/Salmeterol on Sleep Quality in Patients with COPD
    Banta, E. M.
    Mende, C.
    Rhoads, C.
    Craig, T. J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB43 - AB43
  • [8] Effect of fluticasone propionate/salmeterol on arterial stiffness in patients with COPD
    Dransfield, Mark T.
    Cockcroft, John R.
    Townsend, Raymond R.
    Coxson, Harvey O.
    Sharma, Sanjay S.
    Rubin, David B.
    Emmett, Amanda H.
    Cicale, Michael J.
    Crater, Glenn D.
    Martinez, Fernando J.
    RESPIRATORY MEDICINE, 2011, 105 (09) : 1322 - 1330
  • [9] Efficacy of Advair Diskus 250/50 (fluticasone propionate/salmeterol) in patients previously naive to COPD maintenance therapy
    Anzueto, AR
    Sense, W
    Yates, J
    Brown, C
    Knobil, K
    CHEST, 2004, 126 (04) : 808S - 808S
  • [10] Maintenance of bronchodilator response for Advair Diskus 250/50 (fluticasone propionate/salmeterol) but not ipratropium/albuterol in patients with COPD
    Knobil, K
    Kalberg, C
    Merchant, K
    Emmett, A
    Cicale, M
    CHEST, 2004, 126 (04) : 807S - 807S
12345